Healthcare - Biotechnology - NASDAQ - GB
$ 1.05
-1.87 %
$ 43.1 M
Market Cap
-0.66
P/E
Price Target
Average
90.48%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--18.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Achilles Therapeutics plc
Wall Street analysts predict an average 1-year price target for ACHL of $2 , with forecasts ranging from a low of $2 to a high of $2 .
ACHL Lowest Price Target
Wall Street Target
2 USD
90.48%
ACHL Average Price Target
Wall Street Target
2 USD
90.48%
ACHL Highest Price Target
Wall Street Target
2 USD
90.48%
REVENUE FORECAST
Revenue Forecast Chart ACHL
EBIT FORECAST
EBIT Forecast Chart ACHL
NET INCOME FORECAST
Net Income Chart ACHL